Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Aligos Therapeutics Q1 Earnings

Aligos Therapeutics (NASDAQ:ALGS) reported its Q1 earnings results on Thursday, May 4, 2023 at 04:05 PM. Here’s what…
byBenzinga Insights
May 4, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Aligos Therapeutics (NASDAQ:ALGS) reported its Q1 earnings results on Thursday, May 4, 2023 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

Aligos Therapeutics missed estimated earnings by 10.42%, reporting an EPS of $-0.53 versus an estimate of $-0.48.

Revenue was up $152 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 2.94% drop in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Aligos Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: Neogen Q1 Earnings

By Benzinga Insights
September 27, 9:00 AM
Neogen (NASDAQ:NEOG) reported its Q1 earnings results on Tuesday, September 27, 2022 at 08:45 AM. Here's what investors need to know about the announcement. Earnings Neogen beat estimated earnings by 25.0%, reporting an EPS of $0.15 versus an estimate of $0.12.

NEOG

Read More

Recap: Seagen Q2 Earnings

By Benzinga Insights
July 28, 4:35 PM
Seagen (NASDAQ:SGEN) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Seagen beat estimated earnings by 15.12%, reporting an EPS of $-0.73 versus an estimate of $-0.86.

SGEN